Is Teva Pharmaceutical stock a buy?

Yes, Teva Pharmaceutical pays dividends. Last time was Tuesday 12th of December 2017 where the investors holding the stock on Tuesday 28th of November 2017 were paid ILA8.5 per share. Over the last 62 times between 2002 and 2017, Teva Pharmaceutical has paid ILA3774.528 with an average of ILA60.88 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Teva Pharmaceutical 10 years ago, but if you had invested on Tuesday 22nd of October 2019 when the price was ILA2 797.00, you would have made a profit of ILA3 896.00 per share or 139.29%

Yes, the average daily trading liquidity for Teva Pharmaceutical is ILA984 494 thousand. You should therefore be able to get in and out of your positions relatively fast.

Teva Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.06, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Teva Pharmaceutical to be high [0.75 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.